GI Partners (US) completed the acquisition of Logibec (CA), a leading provider of healthcare information technology solutions in Canada, on January 15, 2015. The financial details of the deal were not disclosed. William Blair & Company and William Blair acted as financial advisors to GI Partners, while Harris Williams & Co., National Bank of Canada, and Royal Bank of Canada advised Logibec.

AcquirerGI Partners (US)
TargetLogibec (CA)
Deal valueUndisclosed
Type of dealAcquisition
Date closedJanuary 15, 2015
Buy-side advisorsWilliam Blair & Company, William Blair
Sell-side advisorsHarris Williams & Co., National Bank of Canada, Royal Bank of Canada
Legal buy-sidePaul Hastings LLP, Stikeman Elliot LLP, Paul Hastings, Stikeman Elliott
Legal sell-sideGoodmans LLP, Davies Ward Phillips & Vineberg LLP, Goodmans, Davies Ward Phillips & Vineberg

The acquisition aims to bolster GI Partners' presence in the Canadian healthcare IT market and support Logibec's expansion efforts. The deal reflects a strategic move by private equity firms to leverage growth opportunities within the healthcare sector.

Strategic Rationale

GI Partners, a San Francisco-based investment firm focused on middle-market companies, sought to enhance its portfolio in the burgeoning Canadian healthcare IT segment through this acquisition. Logibec, with expertise in delivering comprehensive information technology solutions for hospitals and clinics, aligns well with GI Partners' goal of fostering innovative technological advancements within the healthcare industry.

Financial Context

The healthcare IT sector has been witnessing significant growth due to increasing demand for efficient management systems and data analytics. The acquisition positions Logibec to capitalize on this trend by leveraging GI Partners’ financial resources, operational expertise, and strategic partnerships.

Outlook

With the transaction now complete, both parties are poised to realize synergies that could include expanded service offerings, enhanced market penetration, and improved technological capabilities. The combined entity is expected to be well-positioned for future growth in a rapidly evolving healthcare landscape.